There are some very clear side effects and adverse events and they occur at quite shocking rates
For patients with commercial insurance, medication co-pays are typically $25 per month but depending on the plan may be higher
But insurance companies want to keep costs down themselves, so many won't cover them for weight loss, or require patients to jump through frustrating hoops to get approval for coverage
hypertension, type 2 DM, dyslipidemia) A meta-analysis of 22 trials involving over 17,000 patients determined that 50.2% and 17.5% of patients treated with GLP-1RAs (exenatide, semaglutide & liraglutide) experienced a weight loss of 5% and 10% compared to placebo, and that patients without type 2 diabetes achieved a significantly greater weight loss compared to those with diabetes (Vosoughi et al, 2022)
Contact your provider if symptoms persist
GLP-1 medications have demonstrated cardioprotective effects in type 2 diabetes, and while data in type 1 diabetes are limited, the potential is promising
